Last updated: 2026-10-19 20:13:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Eton Pharmaceutcials, Inc. (ETON) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $49.18, with a market capitalization of $1.44B and a P/E ratio of 113.34. Over the past 52 weeks, its price has ranged from $14.27 to $66.37. This page covers its latest market performance, valuation, price trends and company information.
$1.44B | |
$50.29 | |
$66.37 | |
$1.95 | |
$50.31 | |
318.06K | |
597.95K | |
113.34 | |
$66.37 | |
$14.27 | |
-- | |
-- |
Eton Pharmaceutcials, Inc. (ETON) is trading at $49.18 in after-hours trading as of 2026-10-19 19:56:35, down 2.25% ($1.13) from the regular-session close of $50.31.
After-hours trading shows how investors are pricing ETON after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Eton Pharmaceutcials, Inc. (ETON) moved from $54.75 to $49.18, representing a decline of 10.18% ($5.57).
The stock traded between $48.56 and $57.00 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 468.03 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 67.0%
ETON is currently trading at $49.18, placing it 67.0% of the way from its 52-week low of $14.27 to its 52-week high of $66.37. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 44 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Eton Pharmaceutcials, Inc. (ETON) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.